Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emidol hydrochloride tablets in HBeAg-positive chronic hepatitis B
CTR20132555Phase 2Active
- Sponsor
- Shenyang Pharmaceutical University
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emidol hydrochloride in Chronic Hepatitis B (CHB), sponsored by Shenyang Pharmaceutical University. Started May 2014; status: active.
02
Drugs
emidol hydrochloride
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on CTR20132555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132555.